Literature DB >> 9774594

Development and evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay based on the 18-kilodalton matrix protein for diagnosis of primary EBV infection.

K H Chan1, R X Luo, H L Chen, M H Ng, W H Seto, J S Peiris.   

Abstract

A new immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) based on the recombinant Epstein-Barr virus (EBV) matrix protein was developed. Compared to indirect immunofluorescence for the detection of IgM antibody to the EBV capsid antigen on clinical specimens, the sensitivity and specificity of the new IgM ELISA were 96 and 96%, respectively.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9774594      PMCID： PMC105330     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Incidence of heterophil antibody responses in children with infectious mononucleosis.

Authors:  G Fleisher; E T Lennette; G Henle; W Henle
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

2.  Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies.

Authors:  G Henle; E T Lennette; M A Alspaugh; W Henle
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

3.  A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody.

Authors:  A S Evans; J C Niederman; L C Cenabre; B West; V A Richards
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

4.  Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.

Authors:  W M van Grunsven; E C van Heerde; H J de Haard; W J Spaan; J M Middeldorp
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

5.  Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus.

Authors:  B Weber; M Brunner; W Preiser; H W Doerr
Journal:  J Virol Methods       Date:  1996-03       Impact factor: 2.014

6.  Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses.

Authors:  C V Sumaya; Y Ench
Journal:  Pediatrics       Date:  1985-06       Impact factor: 7.124

7.  A modified immunofluorescence test for Epstein-Barr virus-specific IgM antibody.

Authors:  G B Harnett; C A Palmer; M R Bucens
Journal:  J Virol Methods       Date:  1985-10       Impact factor: 2.014

8.  Assessment of rapid ELISA test for detection of Epstein-Barr virus infection.

Authors:  B A Matheson; S M Chisholm; D O Ho-Yen
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

9.  Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.

Authors:  W M van Grunsven; W J Spaan; J M Middeldorp
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226
  9 in total
  6 in total

1.  Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection.

Authors:  K H Chan; M H Ng; W H Seto; J S Peiris
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.

Authors:  J Fachiroh; D K Paramita; B Hariwiyanto; A Harijadi; H L Dahlia; S R Indrasari; H Kusumo; Y S Zeng; T Schouten; S Mubarika; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.

Authors:  W Hinderer; D Lang; M Rothe; R Vornhagen; H H Sonneborn; H Wolf
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis.

Authors:  Xia Wang; Kun Yang; Cong Wei; Yuan Huang; Dongchi Zhao
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

5.  Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.

Authors:  Joanne L Casey; Andrew M Coley; Graham Street; Kathy Parisi; Peter L Devine; Michael Foley
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

6.  Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection.

Authors:  J L Casey; A M Coley; K Parisi; M Foley
Journal:  Protein Eng Des Sel       Date:  2008-12-10       Impact factor: 1.650
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.